You are here: Industry Insights > Seizures

News List

FDA approves Eton-Azurity’s Eprontia oral solution for seizures and migraines Pharmaceutical-Technology
November 10, 2021
The US Food and Drug Administration (FDA) has granted approval to Eton Pharmaceuticals and Azurity Pharmaceuticals’ Eprontia (topiramate) oral solution to treat seizures and migraines.
GW Pharma’s Epidyolex scores new EU indication pharmatimes
April 22, 2021
GW Pharmaceuticals’ Epidyolex has received approval from the European Commission (EC) for the treatment of seizures associated with tuberous sclerosis complex (TSC) – its third indication in Europe.
GW Pharmaceuticals Receives European Commission Approval for EPIDYOLEX® (cannabidiol) for the Treatment of Seizures Associated with Tuberous Sclerosis Complex americanpharmaceuticalreview
April 21, 2021
GW Pharmaceuticals plc, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines, today announces that the European Commission (EC) has approved the Type II variation application for EPIDYOLEX® ...
Xeris Pharma gets US FDA fast track designation for diazepam non-aqueous injection to treat acute repetitive seizures expresspharma
October 22, 2020
It was previously granted orphan designations both for the treatment of acute repetitive seizures and for the treatment of Dravet Syndrome.
FDA Approves New Indication for Drug Containing Cannabis for Seizures in Rare Genetic Disease americanpharmaceuticalreview
August 10, 2020
The U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.
FDA approves Epidyolex for treatment of tuberous sclerosis complex-associated seizures europeanpharmaceuticalreview
August 04, 2020
Epidyolex, a cannabidiol oral solution, has been given approval by the FDA to treat seizures associated with tuberous sclerosis complex (TSC).
Fenfluramine Reduces Convulsive Seizures in Dravet Syndrome drugs
December 19, 2019
Among patients with Dravet syndrome, the reduction in frequency of convulsive seizures is greater with fenfluramine than with placebo, according to a study published online in The Lancet.
Clues to Why Epileptic Seizures Can Halt Breathing drugs
September 05, 2019
Higher levels of the brain chemical serotonin are linked to a lower risk of potentially deadly seizure-related breathing pauses in people with epilepsy, researchers say.
More money, more gabapentin worldpharmanews
July 10, 2019
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin...
Strobes at Concerts May Cause Epileptic Seizures drugs
June 13, 2019
A 20-year-old collapsed at a music festival with a first-time epileptic seizure. While terrifying, his case wasn't unique.

Previous page 1 2 Next page